A double-blind placebo-controlled trial of the safety and immunogenicity of a seven valent pneumococcal conjugate vaccine [pneumococcal 7-valent CRM197 vaccine conjugate] in presumed HIV-infected infants.

Trial Profile

A double-blind placebo-controlled trial of the safety and immunogenicity of a seven valent pneumococcal conjugate vaccine [pneumococcal 7-valent CRM197 vaccine conjugate] in presumed HIV-infected infants.

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 15 Dec 2009

At a glance

  • Drugs Pneumococcal 7-valent CRM197 vaccine conjugate (Primary)
  • Indications Pneumococcal infections
  • Focus Adverse reactions
  • Most Recent Events

    • 28 Sep 2008 Primary outcome added as reported by ClinicalTrials.gov.
    • 28 Sep 2008 Actual initiation date added as 1 November 1999 as reported by ClinicalTrials.gov.
    • 28 Sep 2008 Planned end date added as 1 Jun 2005 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top